Cargando…
In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain Metastasis
Brain metastasis (B-Met) from melanoma remains mostly incurable and the main cause of death from the disease. Early stage clinical trials and case studies show some promise for targeted therapies in the treatment of melanoma B-Met. However, the progression-free survival for currently available thera...
Autores principales: | Gaziel-Sovran, Avital, Osman, Iman, Hernando, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668495/ https://www.ncbi.nlm.nih.gov/pubmed/23750336 http://dx.doi.org/10.3389/fonc.2013.00127 |
Ejemplares similares
-
miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells
por: Gaziel-Sovran, Avital, et al.
Publicado: (2012) -
In Vivo miRNA Decoy Screen Reveals miR-124a as a Suppressor of Melanoma Metastasis
por: Moubarak, Rana S., et al.
Publicado: (2022) -
Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions
por: Segura, Miguel F., et al.
Publicado: (2017) -
Impact of Previous Local Treatment for Brain Metastases on Response to Molecular Targeted Therapy in BRAF-Mutant Melanoma Brain Metastasis: A Systematic Review and Meta-Analysis
por: Liao, Guixiang, et al.
Publicado: (2022) -
Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis
por: Gallenga, Carla Enrica, et al.
Publicado: (2022)